Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Amgen and AstraZeneca announce positive results from third and final pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
-
Duaklir® Genuair® approved in the European Union for chronic obstructive pulmonary disease
-
AstraZeneca launches and prices a €750,000,000 7 year bond issue
-
AstraZeneca strategy on track to deliver sustainable growth and value through innovation
-
AstraZeneca announces initiation of development programme for BRILINTA® reversal agent
-
AstraZeneca and Isis Pharmaceuticals to co-develop targeted oligonucleotide delivery methods
-
Amgen and AstraZeneca announce positive results from second pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
-
AstraZeneca to present new data from its growing inflammation and autoimmunity pipeline at American College of Rheumatology 2014 Annual Meeting
-
AstraZeneca to divest Myalept to Aegerion
-
AstraZeneca PLC third quarter and nine months results 2014
Latest articles and press releases
All of our latest press releases and articles are available to explore
